首页> 外文期刊>AIDS >Despite CD4 cell count rebound the higher initial costs of medical care for HIV-infected patients persist 5 years after presentation with CD4 cell counts less than 350 mul.
【24h】

Despite CD4 cell count rebound the higher initial costs of medical care for HIV-infected patients persist 5 years after presentation with CD4 cell counts less than 350 mul.

机译:尽管CD4细胞计数反弹,但在出现CD4细胞计数少于350 mul后的5年中,仍继续为HIV感染患者提供更高的医疗护理初始费用。

获取原文
获取原文并翻译 | 示例
           

摘要

We determined that for HIV patients presenting with CD4 cell counts less than 350 mul the initial higher costs of care persisted over 5 years. Fifty-nine percent of new patients between 1 April 1998 and 1 April 2003 had CD4 cell counts less than 350 mul. Mean first year total costs (Dollars 19 917 Dollars Cdn) were 2.5 times higher than for presentations with CD4 cell counts more than 350 mul (Dollars 7840). Total annual costs of care subsequently decreased to Dollars 15 663 by year 5, but still remained higher (Dollars 8883) than those with CD4 cell counts more than 350 mul despite a median CD4 cell count increase from 134 to 464 mul.
机译:我们确定,对于CD4细胞计数少于350 mul的HIV病人,最初的较高护理费用持续了5年。在1998年4月1日至2003年4月1日期间的新患者中,有59%的CD4细胞计数少于350 mul。第一年的平均总成本(美元19 917美元,Cdn)比CD4细胞计数超过350 mul(美元7840)的演示文稿高2.5倍。随后,每年的总护理成本在第5年下降到15 663美元,尽管CD4细胞计数中位数从134增长到464 mul,但仍比CD4细胞计数超过350 mul的那些更高(Dollars 8883)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号